Clinical Case Study - MS-Associated Chronic Pain and Spasticity
-
Overview
“I’m not even 40 but I feel like I’m 80.”
Johanna presented with chronic neuropathic pain and spasticity in her hands and feet due to multiple sclerosis. It was impacting her mobility and sleep, the effects of which had flowed into her career and finances.
Living with her parents while awaiting NDIS support, medical cannabis seemed like a promising treatment option but posed a risk with her Natalizumab use, requiring sound management to avoid potential hepatic injury. Financial constraints added complexity to accessing medical cannabis.
Discover how Johanna's team crafted an affordable and effective medical cannabis treatment, addressing her pain, sleep issues, and restoring her sense of self.
Preview this case study by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this case study, you’ll be able to:
- Demonstrate an understanding of the pathophysiology of MS
- Discuss common treatment options for MS
- Discuss how cannabinoid-based therapies may be an effective treatment option for symptom management in patients with MS
- Explain the TGA guidance for providing medical cannabis as a treatment for patients with MS
- Collect detailed patient information
- Apply critical safety considerations/risk mitigation strategies for patients presenting with potential for hepatic injury
- Discuss product usage and critical safety considerations with patients in patient-centred care
Overview
“I’m not even 40 but I feel like I’m 80.”
Johanna presented with chronic neuropathic pain and spasticity in her hands and feet due to multiple sclerosis. It was impacting her mobility and sleep, the effects of which had flowed into her career and finances.
Living with her parents while awaiting NDIS support, medical cannabis seemed like a promising treatment option but posed a risk with her Natalizumab use, requiring sound management to avoid potential hepatic injury. Financial constraints added complexity to accessing medical cannabis.
Discover how Johanna's team crafted an affordable and effective medical cannabis treatment, addressing her pain, sleep issues, and restoring her sense of self.
Preview this case study by watching the video above.
Estimated Duration: 1 hour
Access Duration: 12 months from date of purchase
Learning Outcomes
Upon completion of this case study, you’ll be able to:
- Demonstrate an understanding of the pathophysiology of MS
- Discuss common treatment options for MS
- Discuss how cannabinoid-based therapies may be an effective treatment option for symptom management in patients with MS
- Explain the TGA guidance for providing medical cannabis as a treatment for patients with MS
- Collect detailed patient information
- Apply critical safety considerations/risk mitigation strategies for patients presenting with potential for hepatic injury
- Discuss product usage and critical safety considerations with patients in patient-centred care